PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7119568-2	1982	Single intraperitoneal injections of GalN at several dose levels and postinjection exsanguination times resulted in depressed levels of cholesteryl esters, an index of plasma lecithin:cholesterol acyltransferase (LCAT) activity, and increased levels of phospholipids, unesterified cholesterol, and triglycerides.	Galactosamine	37-41	lecithin cholesterol acyltransferase	Rattus norvegicus	175-211	
1906919-0	1991	High density lipoprotein subpopulations from galactosamine-treated rats and their transformation by lecithin:cholesterol acyltransferase.	Galactosamine	45-58	lecithin cholesterol acyltransferase	Rattus norvegicus	100-136	
1906919-1	1991	It is known that an acute hepatotoxicity is produced in rats by intraperitoneal administration of galactosamine; a consequence of this treatment is a marked deficiency of lecithin:cholesterol acyltransferase (LCAT) activity in the plasma compartment.	Galactosamine	98-111	lecithin cholesterol acyltransferase	Rattus norvegicus	171-207	
1906919-1	1991	It is known that an acute hepatotoxicity is produced in rats by intraperitoneal administration of galactosamine; a consequence of this treatment is a marked deficiency of lecithin:cholesterol acyltransferase (LCAT) activity in the plasma compartment.	Galactosamine	98-111	lecithin cholesterol acyltransferase	Rattus norvegicus	209-213	
7119568-2	1982	Single intraperitoneal injections of GalN at several dose levels and postinjection exsanguination times resulted in depressed levels of cholesteryl esters, an index of plasma lecithin:cholesterol acyltransferase (LCAT) activity, and increased levels of phospholipids, unesterified cholesterol, and triglycerides.	Galactosamine	37-41	lecithin cholesterol acyltransferase	Rattus norvegicus	213-217	
746337-5	1978	Cycloheximide, colchicine, 4-amino-pyrazolopyrimidine, and D-galactosamine depress the secretion of both TG and LCAT.	Galactosamine	59-74	lecithin cholesterol acyltransferase	Rattus norvegicus	112-116	
602771-0	1977	The effect of D-galactosamine on LCAT secretion and ultrastructure of isolated rat hepatocytes.	Galactosamine	14-29	lecithin cholesterol acyltransferase	Rattus norvegicus	33-37	
602771-1	1977	The effect of D-galactosamine on secretory activity and morphology of isolated rat hepatocytes was investigated: Galactosamine was found to reduce the secretion of lipoproteins (as indicated by the release of free cholesterol and triacylglycerol) as well as the secretion of lecithin: cholesterol acyltransferase (LCAT) and [14C]-labelled proteins from the isolated cells.	Galactosamine	113-126	lecithin cholesterol acyltransferase	Rattus norvegicus	314-318	
602771-9	1977	The rather selective effect of galactosamine on LCAT secretion suggests the use of this compound for the study of the interrelationship between LCAT and lipoprotein secretion.	Galactosamine	31-44	lecithin cholesterol acyltransferase	Rattus norvegicus	48-52	
812181-0	1975	Lipoprotein and lecithin: cholesterol acyltransferase changes in galactosamine-induced rat liver injury.	Galactosamine	65-78	lecithin cholesterol acyltransferase	Rattus norvegicus	16-53	
812181-1	1975	Abnormal lipoproteins and drcreased lecithin: cholesterol acyltransferase activity are found in rat plasma following intraperitoneal injection of D-galactosamine.	Galactosamine	146-161	lecithin cholesterol acyltransferase	Rattus norvegicus	36-73